CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-14 | ANSTICE DAVID W Director | Exercise or conversion | +7,585 | 84,905 | ||
| 2022-06-14 | ANSTICE DAVID W Director | Exercise or conversion · Restricted Stock Unit Award | −7,585 | 0 | ||
| 2021-12-02 | ANSTICE DAVID W Director | Exercise or conversion | +5,578 | 78,659 | ||
| 2021-12-02 | ANSTICE DAVID W Director | Shares withheld for taxes | −1,339 | $22.11 | $30K | 77,320 |
| 2021-12-02 | ANSTICE DAVID W Director | Exercise or conversion · Restricted Stock Unit Award | −5,578 | 0 | ||
| 2021-07-01 | ANSTICE DAVID W Director | Exercise or conversion | +20,000 | $14.60 | $292K | 93,081 |
| 2021-07-01 | ANSTICE DAVID W Director | Sale | −20,000 | $24.58 | $492K | 73,081 |
| 2021-07-01 | ANSTICE DAVID W Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2021-06-14 | ANSTICE DAVID W Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +15,677 | 15,677 | ||
| 2021-06-14 | ANSTICE DAVID W Director | Grant or award · Restricted Stock Unit Award | +7,585 | 7,585 | ||
| 2021-06-07 | ANSTICE DAVID W Director | Exercise or conversion | +5,000 | $14.60 | $73K | 78,081 |
| 2021-06-07 | ANSTICE DAVID W Director | Sale | −5,000 | $24.00 | $120K | 73,081 |
| 2021-06-07 | ANSTICE DAVID W Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −5,000 | 20,000 | ||
| 2021-05-20 | ANSTICE DAVID W Director | Exercise or conversion | +6,104 | 74,485 | ||
| 2021-05-20 | ANSTICE DAVID W Director | Shares withheld for taxes | −1,404 | $21.92 | $31K | 73,081 |
| 2021-05-20 | ANSTICE DAVID W Director | Exercise or conversion · Restricted Stock Unit Award | −6,104 | 0 | ||
| 2020-12-02 | ANSTICE DAVID W Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +11,509 | 11,509 | ||
| 2020-12-02 | ANSTICE DAVID W Director | Grant or award · Restricted Stock Unit Award | +5,578 | 5,578 | ||
| 2020-09-28 | ANSTICE DAVID W Director | Exercise or conversion | +20,000 | $14.92 | $298K | 86,213 |
| 2020-09-28 | ANSTICE DAVID W Director | Sale | −17,832 | $16.79 | $299K | 68,381 |
Page 1 of 2 · 32 trades